HTG Nominated for a Galien Foundation Medstartup 2018 Award together with Firalis

HTG and Firalis are nominated for Best Innovative Trial Design Leading to Quicker and Better Therapeutic Outcome by the Galien Foundation Medstartup 2018.  

About the Galien Foundation:
The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatment and technologies that will impact human health and save lives.